1/19/2021 6:31:27 AM
Lilly, Merus NV Collaborate To Discover Novel T-Cell Re-Directing Bispecific Antibody Therapies
1/15/2021 6:46:58 AM
Lilly Invests $30 Mln In Unseen Capital Health Fund
1/14/2021 6:46:13 AM
Lilly Elects Gabrielle Sulzberger As New Member, Effective January 25
1/11/2021 8:04:28 AM
FDA Accepts SNDA For Jardiance For Adults With Heart Failure With Reduced Ejection Fraction
1/11/2021 6:32:03 AM
Lilly Says Donanemab Slows Clinical Decline Of Alzheimer's Disease In Positive Phase 2 TRAILBLAZER-ALZ Study
1/7/2021 7:14:24 AM
Precision BioSciences Announces Closing Of In Vivo Gene Editing Collaboration With Eli Lilly
12/21/2020 9:04:01 AM
Principle LTC's Tower Nursing & Rehabilitation Center Joins With Lilly On Phase 3 Drug Trial For COVID-19 Prevention
12/15/2020 6:35:05 AM
Eli Lilly And Co. (LLY) Has Raised Its FY20 Revenue Estimate To $24.2 - $24.7 Bln From $23.7 - $24.2 Bln
12/15/2020 6:34:15 AM
Eli Lilly And Co. (LLY) Has Raised Its FY20 EPS Estimate To 7.45 - 7.65 From 7.20 - 7.40
12/15/2020 6:33:16 AM
Eli Lilly Provides 2021 Financial Guidance, Updates 2020 Outlook